MBRX
Moleculin Biotech Inc
NASDAQ: MBRX · HEALTHCARE · BIOTECHNOLOGY
$2.48
-0.40% today
Updated 2026-05-06
Market cap
$13.39M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-28.42
Dividend yield
—
52W range
$2 – $29
Volume
0.1M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →197 stocks currently score above 75
Price targets
Analyst target
$21.00
+746.77%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-5.37M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-29.02M | $-29.77M | $-21.76M | $-33.56M | $15.55M |
| EPS | — | — | — | — | $-28.42 |
| Free cash flow | $-27.71M | $-24.23M | $-23.88M | $-22.73M | $-5.37M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Moleculin Biotech Inc trades at $2.48. Our Smart Value Score of 26/100 indicates the stock is weak.
Frequently asked questions
What is Moleculin Biotech Inc's stock price?
Moleculin Biotech Inc (MBRX) trades at $2.48.
Is Moleculin Biotech Inc overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Moleculin Biotech Inc (MBRX)?
The analyst target price is $21.00, representing +746.8% upside from the current price of $2.48.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-256.10%
Beta1.74
50D MA$2.35
200D MA$7.90
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—